Retatrutide is a novel investigational peptide that acts as an agonist for three receptors: GIP, GLP-1, and glucagon
Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous
Investigating the Cause: Vitamin B12 or Contaminants
Laboratory research has documented interactions with vascular endothelial growth factor (VEGF) and related growth factors involved in angiogenesis, the formation of new blood vessels, making this a significant area of interest in regenerative research
If a purchase is made through these links, a commission may be earned at no additional cost to the buyer
